Search results for "S'"

showing 10 items of 706 documents

A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial

2019

Abstract Context The CD40-CD154 co-stimulatory pathway plays an important role in the pathogenesis of Graves disease (GD) by promoting autoreactive B-cell activation. Objective Evaluate efficacy and safety of a human, blocking, nondepleting anti-CD40 monoclonal antibody, iscalimab, in hyperthyroid patients with GD. Design Open-label, phase II proof-of-concept study. Setting Multicenter. Patients Fifteen with GD. Intervention Patients received 5 doses of iscalimab at 10 mg/kg intravenously over 12 weeks. Main outcome measures Thyroid-related hormones and autoantibodies, plasma soluble CD40, free CD40 on B cells, soluble CXCL13, pharmacokinetics, and safety were assessed. Results The iscalima…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGraves' diseasemedicine.medical_treatmentClinical BiochemistryContext (language use)Thyroid Function TestsHyperthyroidismProof of Concept StudyBiochemistryGastroenterologyThyrotropin receptorYoung AdultEndocrinologyThyroid peroxidaseInternal medicinemedicineHumansTissue DistributionCD40 AntigensAdverse effectAgedTriiodothyroninebiologybusiness.industryBiochemistry (medical)AutoantibodyAntibodies MonoclonalMiddle AgedPrognosismedicine.diseaseEndocrinologybiology.proteinFemaleThyroglobulinbusinessFollow-Up StudiesThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Are primary-care physician practices related to health behaviors likely to reduce social inequalities in health?

2017

Abstract Our objective was to examine patients' health behaviors and the related practices of their primary-care physicians to determine whether physicians' actions might help to reduce the social inequalities in health behaviors among their patients. Fifty-two general practitioners, who were also medical school instructors in the Parisian area, volunteered to participate. A sample of 70 patients (stratified by sex) aged 40–70 years was randomly chosen from each physician's patient panel and asked to complete a questionnaire about their social position and health behaviors: tobacco and alcohol use, diet, physical activity, and participation in breast and cervical cancer screening. Each phys…

AdultMalemedicine.medical_specialtyEpidemiologyHealth Behavior03 medical and health sciencesBreast cancer screening0302 clinical medicineSex FactorsSurveys and QuestionnairesMedicineSocial positionHumansSocial inequality030212 general & internal medicineSocial determinants of healthPractice Patterns Physicians'030505 public healthmedicine.diagnostic_testPrimary Health Carebusiness.industryPublic Health Environmental and Occupational HealthPrimary care physicianMiddle AgedTest (assessment)DisadvantagedCross-Sectional StudiesSocioeconomic FactorsFamily medicineScale (social sciences)Female0305 other medical sciencebusinessPreventive medicine
researchProduct

Graves ophthalmopathy: role of MR imaging in radiation therapy.

1991

Twenty-three patients with Graves ophthalmopathy who underwent radiation therapy were monitored by means of magnetic resonance (MR) imaging. T2 relaxation times of extraocular muscles and orbital fat, areas of extraocular muscles, and degree of exophthalmos were measured by means of MR imaging at the beginning, at the end, and 3 months after completion of radiation therapy. As a result, patients with primarily elevated T2 times of extraocular muscles showed a better therapy response regarding muscle thickening than patients with primarily normal T2 times. Elevated T2 times, which probably represent acute inflammatory changes, were markedly decreased at the end of therapy. Therefore, quantit…

AdultMalemedicine.medical_specialtyExophthalmosmedicine.medical_treatmentEye diseaseEyeExtraocular musclesGraves' ophthalmopathyImmunopathologymedicineHumansRadiology Nuclear Medicine and imagingExophthalmusAgedmedicine.diagnostic_testbiologybusiness.industryMagnetic resonance imagingMiddle Agedbiology.organism_classificationmedicine.diseaseMagnetic Resonance ImagingGraves Diseaseeye diseasesSurgeryRadiation therapymedicine.anatomical_structureOculomotor MusclesFemalemedicine.symptombusinessNuclear medicineRadiology
researchProduct

Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.

1986

Forty patients with Graves' ophthalmopathy stages III-V were divided into two groups in a random manner according to their year of birth. Group I received prednisone in decreasing dosage. Group II received prednisone at a comparable dosage and ciclosporin. Steroids were discontinued after 10 weeks in the two groups. In the patients of group II, ciclosporin was continued over 12 months. The therapeutic effect was assessed by an activity score based on subjective and objective symptoms (computerized tomography and sonography of the orbit, Hertel values, clinical findings). All signs of endocrine ophthalmopathy improved significantly in both groups (P less than 0.01 in group I; P less than 0.0…

AdultMalemedicine.medical_specialtyEye DiseasesClinical BiochemistryVisual AcuityCyclosporinsBiochemistryGastroenterologylaw.inventionGraves' ophthalmopathyPharmacotherapyRandomized controlled triallawPrednisoneInternal medicinemedicineHumansProspective StudiesProspective cohort studyClinical Trials as TopicDose-Response Relationship Drugbusiness.industryTherapeutic effectGeneral MedicineMiddle AgedCiclosporinmedicine.diseaseGraves DiseaseClinical trialEndocrinologyPrednisoneDrug Therapy CombinationFemalebusinessmedicine.drugFollow-Up StudiesEuropean journal of clinical investigation
researchProduct

Retrobulbar adipocytes and humoral immunity in Graves' ophthalmopathy

1993

As CT and MR-imaging revealed an enlargement of retrobulbar fat tissue in patients with Graves' ophthalmopathy, the role of the retrobulbar adipocytes in the pathogenesis of this disorder remains to be elucidated. To evaluate the in vitro influence of humoral immunity on retrobulbar adipose tissue, the effects of IgG and sera from 56 euthyroid ophthalmopathy patients and 53 controls on both porcine and human (patients' and controls') retrobulbar adipocytes were measured by means of several assays: An enzyme-linked immunosorbent assay was employed to reveal specific binding of antibodies to the adipocytes. Metabolic activity was determined by means of a colorimetric dimethyl thiazolium-diphe…

AdultMalemedicine.medical_specialtyEye DiseasesSwineEndocrinology Diabetes and MetabolismGraves' diseaseClinical BiochemistryAdipose tissueEnzyme-Linked Immunosorbent AssayEyeBiochemistryImmunoglobulin GGraves' ophthalmopathychemistry.chemical_compoundEndocrinologyInternal medicineAdipocytemedicineAdipocytesAnimalsHumansCells CulturedAgedLipoprotein lipasebiologybusiness.industryBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseGraves DiseaseKineticsEndocrinologychemistryImmunoglobulin GHumoral immunityAntibody Formationbiology.proteinFemaleAntibodybusiness
researchProduct

Urinary glycosaminoglycans in Graves' ophthalmopathy.

1990

An increased accumulation of glycosaminoglycans (GAG) in retrobulbar tissues has been reported in patients with thyroid eye disease. We examined the quantitative urinary GAG excretion in 101 patients with Graves' ophthalmopathy of different classes, 36 patients with Graves' hyperthyroidism without ophthalmopathy, 14 patients with toxic nodular goitre and 103 control subjects. Glycosaminoglycans were isolated from 24-h urine collections by precipitation with cetylpyridinium chloride and ethanol followed by photometrical quantification of hexuronic acids after reaction with carbazole. In comparison with the control group (15.8, 10.4, 21.6 mg/24 h; median, 25th, 75th percentile) a significant …

AdultMalemedicine.medical_specialtyGoiterAdolescentEndocrinology Diabetes and MetabolismGraves' diseaseUrinary systemUrineGraves' ophthalmopathyExcretionEndocrinologyInternal medicineImmunopathologymedicineHumansAgedGlycosaminoglycansAged 80 and overbusiness.industryThyroidMiddle Agedmedicine.diseaseCombined Modality TherapyGraves DiseaseEndocrinologymedicine.anatomical_structurePrednisoneFemalebusinessGoiter NodularClinical endocrinology
researchProduct

Does thyroid surgery for Graves' disease improve health-related quality of life?

2012

Abstract PURPOSE: Graves' disease can induce alterations of the psychosocial well-being that negatively influence the overall well-being of patients. Among the current treatments, surgery has limited indications, and its impact on the health-related quality of life has not been well clarified. The aim of this study was to assess the impact of surgery on the quality of life. METHODS: Fifty-seven patients who underwent total thyroidectomy for Graves' disease in our surgical unit between April 2002 and December 2009 were administered a questionnaire concerning four issues: organic alterations and clinical manifestations, neurovegetative system disturbances, impairment of daily activities, psyc…

AdultMalemedicine.medical_specialtyGraves' diseaseDiseaseSettore MED/42 - Igiene Generale E ApplicataQuality of lifeSurgical oncologySurveys and QuestionnairesActivities of Daily LivingmedicineHumansPostoperative PeriodRetrospective StudiesHealth related quality of lifeTotal thyroidectomyQOLbusiness.industryThyroidGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheGraves DiseaseSurgerystomatognathic diseasesSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurePreoperative PeriodGraveQuality of LifeThyroidectomySurgeryFemalebusinessPsychosocialSurgery today
researchProduct

Prevalence of myxomatous mitral valve prolapse in patients with lymphocytic thyroiditis

1995

Abstract In conclusion, given the cardiac (mitral regurgitation, endocarditis, thromboembolic complications, arrhythmic sudden death) and neurologic (cerebral embolic event) complications of the pathologic forms of MVP, 6,8 physicians should look carefully for myxomatous involvement of the mitral valve and prolapse in patients with autoimmune thyroid diseases. Patients should be monitored and prophylactic antibiotic treatment recommended when appropriate.

AdultMalemedicine.medical_specialtyGraves' diseaseSudden deathInternal medicineMitral valvemedicineHumansEndocarditisAgedAutoimmune diseaseMitral regurgitationMitral Valve Prolapsebusiness.industryThyroidThyroiditis AutoimmuneMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureEchocardiographycardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessLymphocytic ThyroiditisThe American Journal of Cardiology
researchProduct

Current practice of chronic hepatitis B treatment in Southern Italy

2012

Abstract Background Treatment choice for chronic HBV infection is a continuously evolving issue, with a wide range of options. We aimed to evaluate the current practice of HBV therapies in the real world in Southern Italy. Methods A prospective study enrolling over a six month period (February–July 2010) all consecutive HBsAg positive subjects, never previously treated, referred to 16 liver units in two Southern Italy regions (Calabria and Sicily). Results Out of 247 subjects evaluated, 116 (46.9%) had HBV-DNA undetectable or lower than 2000 UI/ml. There were 108 (43.7%) inactive carriers, 103 (41.7%) chronic hepatitis, and 36 (14.6%) liver cirrhosis. Antiviral treatment was planned in 94 (…

AdultMalemedicine.medical_specialtyHBsAgGuanineCirrhosisOrganophosphonatesPyrimidinonesNucleosides analoguesAntiviral AgentsPolyethylene GlycolsYoung AdultHepatitis B ChronicChronic hepatitisInterferonPegylated interferonInternal medicineHBVInternal MedicinemedicineHumansHepatitis B e AntigensPractice Patterns Physicians'TenofovirProspective cohort studyAgedAged 80 and overTelbivudinebusiness.industryAdenineAge FactorsInterferon-alphaNucleosidesMiddle AgedHBV; Interferon; Nucleosides analogues; Nucleotides analoguesNucleotides analoguesmedicine.diseaseRecombinant ProteinsItalyLamivudineCurrent practiceImmunologyInterferonFemalePreviously treatedbusinessThymidinemedicine.drugEuropean Journal of Internal Medicine
researchProduct

Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity

2019

Lacrimal gland (LG) involvement in patients with Graves ophthalmopathy (GO) has been considered as a potential cause of the associated GO symptoms and different studies demonstrated the LG involvement in patients with GO than healthy controls. The aim of this study was to evaluate LG involvement, through measurement of its herniation, using a magnetic resonance imaging (MRI) index, in patients with different GO activities. Thirty-two consecutive Caucasian patients affected by GO were enrolled and grouped in group A (16 with inactive GO, CAS < 3) and B (16 with active GO, CAS ≥ 3) according to their GO activity. All patients underwent clinical-endocrinological assessment, a complete ocular e…

AdultMalemedicine.medical_specialtyHerniaTrabLacrimal glandSeverity of Illness IndexGastroenterologySettore MED/13 - Endocrinologia030218 nuclear medicine & medical imagingGraves' ophthalmopathy03 medical and health sciencesMagnetic resonance imaging0302 clinical medicineInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingStage (cooking)Lacrimal apparatuAgedmedicine.diagnostic_testSettore MED/30 - Malattie Apparato Visivobusiness.industryThyroidLacrimal ApparatusSettore MED/37 - NeuroradiologiaOrbital diseasesMagnetic resonance imagingGeneral MedicineMiddle AgedGraves ophthalmopathymedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisBiomarker (medicine)FemaleRadiologySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessHormoneEuropean Radiology
researchProduct